Safety of third dose of COVID-19 vaccination in frail patients: Results from the prospective Italian VAX4FRAIL study

IMPORTANCE: Despite people with impaired immune competence due to an underlying disease or ongoing therapy, hereinafter frail patients, are (likely to be) the first to be vaccinated, they were usually excluded from clinical trials. OBJECTIVE: To report adverse reactions of frail patients after recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Cosimo, Serena, Lupo-Stanghellini, Maria Teresa, Costantini, Massimo, Mantegazza, Renato, Ciceri, Fabio, Salvarani, Carlo, Zinzani, Pier Luigi, Mantovani, Alberto, Ciliberto, Gennaro, Uccelli, Antonio, Baldanti, Fausto, Apolone, Giovanni, Delcuratolo, Sabina, Morrone, Aldo, Locatelli, Franco, Agrati, Chiara, Silvestris, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631315/
https://www.ncbi.nlm.nih.gov/pubmed/36338743
http://dx.doi.org/10.3389/fonc.2022.1002168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631315/
https://www.ncbi.nlm.nih.gov/pubmed/36338743
http://dx.doi.org/10.3389/fonc.2022.1002168

Ejemplares similares